Source: ClinicalTrials.gov
PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study
View on ClinicalTrials.govCitation record
- Study start
- 2026-10-14
- NCT number
- NCT07874828
- Phase
- Phase2
- Overall status
- Recruiting
- Study type
- Interventional
- Lead sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 30 participants
- Conditions
- Sarcoma,Soft Tissue
- Interventions
- Tirzepatide (Drug)
- Last updated at source
- 20 Oct 2026
- Original source
- https://clinicaltrials.gov/study/NCT07874828
This page reproduces citation metadata only. Inclusion in the Avion Science research library does not imply endorsement and does not establish the safety, efficacy or intended use of any Avion Science compound. Refer to the original record for complete study information.